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Abstract 
Background: Decreased physical capacity and increased systemic inflammatory response are fre-
quently observed in patients with chronic obstructive pulmonary disease (COPD). The relation-
ship between the inflammatory response and disease severity and the immunological response to 
exercise were addressed in COPD. Objective: The first objective was to identify systemic biomark-
ers and their relationship with COPD severity. The second objective was to examine the effect of 
both acute exercise and pulmonary rehabilitation on these biomarkers. Methods: Forty subjects 
participated in the study. Thirty-two patients with moderate or severe COPD and 8 healthy non- 
smokers completed the study. Spirometry was preformed. Physical capacity was determined by a 
progressive symptom-limited cycle ergo meter (incremental) test. Blood samples were analyzed 
for C-reactive protein (CRP), pro-inflammatory cytokines (IL-6, TNF-α), pro-fibrotic cytokines 
(TGF-β) and oxidative burst in circulating leukocytes before and after exercise, and before and af-
ter pulmonary rehabilitation. Results: IL-6, CRP, WCC and TGF-β were higher in COPD (p < 0.05) 
than eight healthy controls. WCC, IL-6, TNF-α, CRP and TGF-β were negatively related to forced ex-
piratory volume in 1 s (FEV1) (r = 0.4054, 0.3221, 0.1528, 0.1846 and 0.1187, respectively). Acute 
exercise increased circulating leucocytes and oxidative stress in both groups (p = 0.000, 0.0049 
respectively), while IL-6 was increased in COPD group ((p = 0.0115) and circulating TNF-α in 
healthy control (p = 0.0369). Pulmonary rehabilitation didn’t modify the levels of inflammatory 
mediators. Conclusions: Reduced lung function is associated with increased levels of systemic in-
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flammatory markers and acute exercise can further increase this inflammatory response. Howev-
er pulmonary rehabilitation is unlikely to exacerbate systemic inflammation in COPD. 
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1. Introduction 
Chronic obstructive pulmonary disease (COPD) is a complex condition characterised by chronic cough and 
sputum reflecting airway inflammation and more importantly progressive airflow limitation with variable alveo-
lar destruction. In more recent times systemic inflammation with extra pulmonary manifestations that include 
muscle wasting has also been identified [1]. 
Inflammation in COPD is complex involving many different cells and molecules. The extent and severity of 
inflammation may also be estimated by measurement of oxidative stress and concentrations of inflammatory 
mediators and acute-phase proteins [2]-[6]. C-reactive protein (CRP), an acute-phase protein synthesized pre-
dominantly by hepatocytes in response to tissue damage or inflammation has been reported as a predictor of 
lung function decline and mortality in COPD [7] [8]. CRP increases the production of pro-inflammatory cyto-
kines [9]. Tumour necrosis factor-alpha (TNF-α) plays an important role as a mediator of cachexia in cancer, 
chronic heart failure, and cystic fibrosis [10]. Circulating levels of TNF-α and interleukin-6 (IL-6) are elevated 
in COPD [11]. Transforming Growth Factor-beta (TGF-β) and oxidative stress are biomarkers that may also 
play a role in the pathogenesis of COPD. TGF-β, stored in platelets and released from platelets in inflammatory 
conditions plays a crucial role in tissue repair [12]. TGF-β is elevated in all stages of COPD being highest in 
GOLD stage 4 [12]. Oxidative stress represents an imbalance between the production of reactive oxygen species 
(ROS) including free radicals, reactive oxygen and nitrogen species and protective antioxidants (such as super-
oxide dismutase and glutathione peroxidase) [13]. Oxidative stress is involved in the skeletal muscle dysfunction 
observed in COPD [14] [15]. Direct measurements of oxidative stress are difficult since ROS/free radicals are 
highly reactive and also short-lived. Rahman et al. [16] were the first to show evidence of systemic oxidative 
stress in patients with COPD.  
The forced expiratory volume in 1 sec (FEV1) is accepted in reflecting the severity of COPD [17]. Capacity 
for gas transfer, exercise capacity, muscle strength, and symptom severity are additionally required to measure 
disease severity. However, there is no characterized and accepted systemic biomarker profile for assessing 
COPD severity and evaluating the effectiveness of treatment. Systemic biomarkers may aid with the assessment 
of disease severity and even guide therapeutic interventions. 
Exercise training is a recognized therapeutic intervention in COPD. Exercise alters both the number and func-
tion of cells of the innate immune system [18]. During exercise, muscles release IL-6 and exercise has been 
shown to provoke the secretion of pro- and anti-inflammatory cytokines, including IL-6 which may attenuate 
TNF-alpha production [19]-[21]. As patients with COPD demonstrate systemic inflammation at rest, exercise 
could further increase inflammatory mediators [22]. 
The intensity, duration and type of exercise can influence immune parameters [23] [24]. Exercise training re-
duces circulating CRP and other inflammatory markers in healthy people and patients with heart failure [25] 
[26]. Resistance training has been shown to reduce muscle TNF-α in healthy older subjects [27]. Exercise and 
rehabilitation in patients with COPD may have similar anti-inflammatory effects [28] [29]. 
The first objective of the current study was to identify the relationship between a wide range of systemic bio-
markers and COPD severity. The second objective was to examine the effect of acute exercise on these bio-
markers. The last objective was to examine the effect of pulmonary rehabilitation on these biomarkers. High 
sensitivity CRP, TNF-α, IL-6, TGF-β, WCC, neutrophils and oxidative stress were measured. 
2. Methods 
2.1. Study Population 
Forty subjects participated in the study; 32 (27 were male) had stable COPD and 8 were healthy subjects (4 were 
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male). Subjects with concomitant diseases such as infection, heart failure, cancer, severe endocrine, hepatic, or 
renal diseases, and systemic autoimmune or connective tissue disorders were excluded from the study. All pa-
tients were stable for at least 3 months. The control subjects with normal pulmonary function had never smoked. 
The medical treatment of patients at the time of the study mainly included inhaled therapy in the form of 
long-acting β2 agonists, anticholinergic and corticosteroids. Four patients were on regular systemic corticoster-
oids and five were on supplemental oxygen therapy. Written, informed consent was obtained and the study was 
approved by the Clinical Research Ethics Committee of Cork Teaching Hospitals (ECM 4 (e) 01/08/06). The 
study was started on the 1st August 2006 and was completed on the 30th June 2008. 
2.2. Pulmonary Function and Cardiopulmonary Exercise Test 
Pulmonary function was performed using a Jaeger Master Screen Pneumo® device (Jaeger Co., Hoechberg, 
Germany). All subjects completed incremental (5 W/min bicycle test) until exhaustion [19] cardiopulmonary 
exercise test (CPET) using the Master Screen CPX (ViaSys Healthcare, Hoechberg, Germany). Subjects per-
formed a maximal incremental test. Controls performed a submaximal (endurance) CPET at 75% of the maxi-
mum incremental CPET power output one week later. Endurance time was standardized at 12 min, which was 
the mean endurance time of the patients with COPD at baseline.  
2.3. The Rehabilitation Program 
Patients attended outpatient pulmonary rehabilitation, which consisted of exercise and education sessions, twice 
weekly for 8 weeks. In addition to this, patients were required to complete 20 minutes of home exercise each 
day, five times a week. Each rehabilitation session comprised one hour of exercise followed by an education 
session. Exercises were a mixture of functional aerobic and resistance activities-walking and cycling, sit to 
stands, step-ups and upper limb work. 
2.4. Health Status 
Health-related quality of life was measured before and after PR with the Chronic Respiratory Disease Question-
naire (CRDQ), St. George’s Respiratory Questionnaire (SGRQ), and hospital anxiety and depression question-
naire [20] [21]. 
2.5. Cytokine Measurements 
Plasma and serum were obtained by centrifugation and stored at –80˚C until analysis. Samples gathered before 
and after PR were processed in the same run and measured in duplicate. Analyses were performed using quantit-
ative sensitivity and high-sensitivity sandwich enzyme-linked immune-sorbent assays (ELISA) (R & D systems, 
Minneapolis, MN). Detection limits for TNF-α, IL-6 and TGF-B were 0.11, 0.039, and 4.61 pg·mL−1, respec-
tively. Inter- and intra-assay precision (coefficients of variances) for these markers were below 7%. 
2.6. Oxidative Stress Measurement 
Fifteen millilitres of venous blood was obtained at rest, at peak exercise, and 30 min later. Cell isolation was 
performed by dextrane sedimentation followed by Hypaque-Ficoll density centrifugation [22]. Contaminating 
erythrocytes were lysed in a lysis buffer solution and cells were washed in Hanks Balanced Salt Solution. Vi-
ability (by trypan blue exclusion) was greater than 95%. Purity of PMNs was 98% by cytocentrifugation and 
staining.  
Production of reactive oxygen species by neutrophil granulocytes in response to stimulation, the oxidative or 
respiratory burst, was measured in isolated neutrophils. The oxidative response was reflected by measures of 
free radical production of neutrophils, and the reduced form of glutathione (GSH).  
Luminol-enhanced chemiluminescence was measured in 96-well microplates at 37˚C for 120 min in a highly 
sensitive luminometer (VeritasTM Microplate Luminometer, Turner BioSystems, USA). Per well, 20 µL of Lu-
minol (10−4 M) was added to 100 µL of neutrophil suspension (2 × 106 cells per milliliter) that was unstimulated 
or stimulated with 20 µL of phorbol myristate acetate (5 µg·mL−1). Luminescence peak height, as a measure for 
maximum oxygen radical production, was expressed in relative light units per second (RLU·s−1). 
A. I. El Gammal et al. 
 
 22 
GSSG was measured using a fluorimetric method described previously by Hissin [23] which was sufficiently 
sensitive and reproducible to provide a valid estimate of oxidative stress. All tests were performed and samples 
were collected at the same time of day. 
2.7. Statistical Analysis 
Linear regression analyses were performed to test the relationship between FEV1 and inflammatory mediators. 
Repeated measures analysis of variance (ANOVA) was used to analyse differences between control and COPD 
and all responses to exercise with effects of different time points (baseline, peak and post exercise), group, and 
the interaction between the two. Statistical significance was taken at the p < 0.05 level. Statistical significance 
was taken at the p < 0.05 level. Results are presented as means ± SE. Sizes of effect are presented as a mean 
difference and its 95% confidence interval (95% CI). Analyses were performed using Statistica programme ver-
sion 12 (STAT, Tulsa, OK, USA). 
3. Results 
3.1. Baseline Characteristics 
Comparisons between the COPD group and healthy participants are summarised in Table 1. Among the COPD 
patients there were more males and the average age was higher. COPD group showed moderate to severe air-
flow obstruction and reduced exercise capacity. As a supplement of severity, four patients were receiving long 
term low dose oral corticosteroids, 5 were on supplemental oxygen and the poor values of health status ques-
tionnaires. 
3.2. Systemic Inflammation in COPD  
Mean values of total circulating leukocytes, neutrophils as well as CRP, IL-6 and TGF-B levels were signifi-
cantly higher in COPD patients, Figure 1. No significant differences between COPD patients and healthy sub-
jects were measured in TNF-α, oxidative stress and GSSG levels. 
 
Table 1. Baseline characteristics.                                                                            
 COPD N = 32 Healthy Control N = 8  
Variables Mean ± SD Minimum-Maximum Mean ± SD Minimum-Maximum p-Value 
Male/Female 25/7  4/4   
Age, yrs 66.06 ± 9.63 42.00 - 84.00 58.75 ± 2.31 56.00 - 62.00 0.041 
BMI, kg∙m−2 23.40 ± 4.65 14.40 - 31.20 26.00 ± 6.54 21.90 - 41.80 0.201 
Pack*Years 65.06 ± 50.96 3.2 - 268 0.0  0.001 
FEV1, L 1.04 ± 0.33 0.44 - 1.76 3.41 ± 0.78 2.95 - 4.77 0.000 
FEV1, % predicted 42.04 ± 17.11 19.20 - 84.20 126.70 ± 47.43 89.50 - 235.60 0.000 
Wmax, W 43.10 ± 13.40 21.00 - 70.00 119.00 ± 32.74 76.00 - 169.00 0.000 
SGRQ Total 56.03 ± 15.36 23.52 - 84.25    
CRDQ Dyspnoea, points 11.53 ± 4.48 0.00 - 22.00    
CRDQ Fatigue, points 14.78 ± 5.66 4.00 - 25.00    
CRDQ Emotional, points 29.84 ± 10.44 7.00 - 47.00    
CRDQ Mastery, points 15.91 ± 5.51 6.00 - 27.00    
HAD Depression 7.06 ± 3.95 0.00 - 18.00    
HAD Anxiety 7.57 ± 4.45 0.00 - 16.00    
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Figure 1. Mean values of baseline leucocytes, CRP, TGF-β and IL-6 in healthy subjects and patients with COPD. *p < 
0.05. Vertical bars denote 0.95 confidence intervals.                                                          
3.3. The Relationship between Disease Severity and Inflammatory Markers 
Linear regression analysis showed a significant negative association between FEV1 and WCC, IL-6, CRP, 
TNF-alpha and TGF-β, Table 2, Figure 2. No significant relationship was observed between FEV1 and oxida-
tive stress or GSSG.  
3.4. Exercise Induced Cytokine Response 
Acute exercise caused an increase of circulating leukocytes in both COPD patients and healthy subjects, fol-
lowed by a decrease 30 minutes post exercise, Figure 3. Although the mean numbers of leucocytes were signif-
icantly higher in COPD patients compared with healthy subjects, the response to exercise was higher in healthy 
control (group effect p = 0.0006). Unlike healthy control, the total numbers of leucocyte count in COPD patients 
failed to return back to baseline level 30 minutes post exercise and that was also reflected in the total neutrophil 
count.  
Acute exercise caused an increase in oxidative burst which continued to increase 30 minutes post exercise and 
the response was comparable in both groups, Figure 4. GSSG levels were increased in COPD patients but not in 
the healthy control, Figure 5. There was an increase in IL-6 levels in the COPD group with exercise but not in 
the healthy group and this effect was more significant in all subjects combined together, Figure 6. Unlike IL-6, 
TNF-α was increased in the healthy group with exercise but not in COPD patients, Figure 7. 
3.5. Effects of Rehabilitation 
3.5.1. Symptom and Physiologic Responses to Rehabilitation 
In patients with COPD, there were statistically significant improvements in all domains of the SGRQ, CRDQ  
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Figure 2. Relationship between inflammatory markers and COPD severity at baseline. COPD, chronic obstructive pul-
monary disease. Vertical bars denote 0.95 confidence intervals.                                                
 
Table 2. Linear regression analysis for all subjects.                                                            
Y = b0 + b1*FEV1 % predicted 
  b
* SE b SE t p r SEE 
CRP b0   5614.166 488.5252 11.4921 0.0000 0.1846 4548.6 
 b1 −0.1846 0.0610 −21.380 7.0593 −3.0286 0.0027   
IL-6 b0   5.6868 0.3671 15.4916 0.0000 0.3221 3.4113 
 b1 −0.3221 0.0580 −0.0286 0.0052 −5.5483 0.0000   
TNF-α b0   1.7892 0.0784 22.8126 0.0000 0.1528 0.7342 
 b1 −0.1528 0.0603 −0.0028 0.0011 −2.5353 0.0118   
TGF-β b0   11943.70 656.1620 18.2024 0.0000 0.1187 6097.5 
 b1 −0.1187 0.0609 −17.95 9.2079 −1.9493 0.0523   
OS b0   231.8830 10.4992 22.0858 0.0000 0.1409 78.535 
 b1 0.1409 0.0746 0.2500 0.1324 1.8880 0.0607   
WCC b0   10.0514 0.3434 29.2666 0.0000 0.4054 2.403 
 b1 −0.4054 0.0727 −0.0225 0.0040 −5.5739 0.0000   
GSSG b0   97.8143 5.0036 19.5487 0.0000 0.0680 37.746 
 b1 −0.0680 0.0744 −0.0562 0.0615 −0.9144 0.3617   
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Figure 3. Acute exercise induced leucocytosis in COPD patients and healthy subjects. *p = 0.000, vertical bars denote 
0.95 confidence intervals. Vertical lines denote 95% CI.                                                       
 
   
Figure 4. Acute exercise causes an increase in oxidative stress in both COPD patients and healthy subjects. *p = 0.00713, 
**p = 0.01065, vertical bars denote 0.95 confidence intervals.                                                   
 
 
Figure 5. GSSG response to acute exercise. GSSG, glutathione disulfide. *p = 
0.00040.                                                               
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Figure 6. Effect of acute exercise on plasma concentration of IL-6. There was an increase in IL-6 levels in the COPD 
group with exercise but not in the healthy group and this effect was more significant in all subjects combined together. *p 
= 0.01155, vertical bars denote 0.95 confidence intervals.                                                     
 
 
Figure 7. Effect of acute exercise on plasma concentration of TNFα-. *p = 
0.03692, vertical bars denote 0.95 confidence intervals, repeated measures 
ANOVA.                                                         
 
and HADQ after PR. Among the patients who performed endurance CPET a significant increase in the exercise 
duration after PR (p = 0.0003, 468 vs 815 seconds). No differences in VO2max or VCO2max were noted post reha-
bilitation. 
3.5.2. The Inflammatory Response to Pulmonary Rehabilitation  
Disappointedly, there was no modification in any of the inflammatory mediators with rehabilitation, Table 3, 
Figure 8. 
4. Discussion 
This study provides evidence that stable COPD patients have a pro-inflammatory state, with increased circulat-
ing levels of inflammatory cells, cytokines and acute-phase reactants. We were unable to detect differences in 
circulating TNF-α between healthy controls and patients with COPD. Although TNF is a key stimulus of IL-6 
production and similar relationship might be expected, the relatively short serum half-life of TNF compared 
with IL-6 and CRP may explain the failure to find the same relationship.  
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Figure 8. The inflammatory response to pulmonary rehabilitation. GSSG le-
vels were unaltered after exercise but instead there was trend toward reduc-
tion in GSSG values but didn’t reach statistical significance. GSSG, gluta-
thione disulfide. *p = 0.04829.                                         
 
Table 3. Mean values of inflammatory mediators before and after pulmonary rehabilitation in patients with chronic obstruc-
tive pulmonary disease.                                                                                        
 Pre-Rehabilitation Post-Rehabilitation  
 Mean −95% CI +95% CI Mean −95% CI +95% CI p 
CRP 4151.87 1845.25 6458.51 5333.179 1845.928 8820.43 0.246 
IL-6 4.67 2.64 6.70 4.41 2.04 6.79 0.666 
TNF 1.63 1.21 2.05 1.61 1.07 2.16 0.871 
TGF-b 12042.12 8720.89 15363.35 11422.26 8321.01 14523.52 0.616 
WCC 9.31 6.33 12.29 9.24 5.90 12.58 0.910 
OS 246.01 171.46 320.55 249.48 186.39 312.57 0.866 
GSSG 97.86 62.49 133.23 91.00 59.86 122.14 0.247 
 
COPD constitutes an independent factor for the elevation of many of the analyzed systemic biomarkers, 
which in the case of CRP, TNF-α, IL-6, TGF-β and WCC is also dependent on severity. We have shown an in-
verse relationship between the levels of these markers and FEV1 % predicted. Total leucocyte count had the 
strongest negative relationship with FEV1. 
This inverse relationship between FEV1 and systemic inflammatory markers, especially in the presence of 
airway obstruction, has been linked to systemic complications in COPD.  
4.1. Inflammatory Response to Acute Exercise in COPD 
Leukocytosis, of which the major component was a raised neutrophil count, was found to be higher following 
exercise in COPD subjects than in healthy control. However, the number of leukocytes in the COPD patients 
was already higher at rest and the response was even higher in healthy subjects (group effect p = 0.0006). One 
can also conclude that the exercise-induced inflammatory response was higher but not exaggerated in COPD. 
Van Helvoort [22] [30] had showed similar results. “Leucocytosis of exercise” has been described as early as 
1893. However, in this study, unlike healthy control, the total WCC didn’t return to baseline post exercise in 
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COPD patients suggesting intensified systemic inflammation.  
There was an increase in IL-6 with exercise in the COPD group despite the relatively low external workload 
and the increase was more pronounced when the two groups combined together, Figure 6. Ostrowski et al. [31] 
showed 128-fold increase after a marathon race compared to baseline levels. Several studies have investigated 
the response of IL-6 to exercise in COPD patients, but the results are mixed. While Van Helvoort [30] demon-
strated an aggravated response of IL-6 in patients with muscle-wasted COPD after maximal exercise, Rabino-
vich [32] did not. 
Unlike IL-6, TNF-α does not seem to increase after exercise in COPD, but increased in healthy subjects. The 
findings on the response of TNF-α to exercise in COPD patients are inconsistent. Whereas van Helvoort et al. 
[30] were unable to find any increases in the levels of TNF-α after exercise; Rabinovich [32] did found an in-
crease of circulating TNF-α in COPD after exercise. 
TGF-β1 has been reported to play a major role in the pathogenesis of fibrosis and emphysema in COPD [33]. 
In the lung, there is increased expression of TGF-β1 in the airway epithelium of COPD patients which has been 
associated with enhanced fibrotic airway remodeling [33]. However, the role of circulating TGB-β is not clear. 
There was an increase in TGF-β in patients with COPD in this study bur there was no change with exercise 
while another study showed elevated TGF-β levels after extensive exercise [34]. Other studies showed stage- 
dependent correlation between serum TGF-β and lung function parameters in patients with COPD [12]. Our ob-
servation that median TGF-β1 serum concentrations were rising with increasing disease severity supports that 
this mediator plays a role in disease pathogenesis. However, we did not find a significant association between 
TGF-β1 and exercise suggesting that the role of TGF-β1 in the pathogenesis of structural changes in COPD 
might be more complex.  
Oxidative stress is another marker of systemic inflammation and this study showed increased oxidative burst 
with exercise which was comparable in COPD and control. Another study showed that in COPD patients, but 
not in healthy subjects, ROS seem to increase after exercise [35]. 
The most important antioxidant is glutathione (GSH), a low-molecular-weight molecule present in muscle at 
millimolar concentrations. GSH inactivates ROS and other biologic oxidants, forming glutathione disulfide 
(GSSG) as the oxidation by-product. GSSG is then recycled enzymatically to GSH. This cycle is interconverta-
ble; GSH is continually being oxidized to GSSG and resynthesized within mammalian cells. The balance be-
tween GSH and GSSG can be used to assess overall oxidative stress within the cell [36]. In the current study, 
acute exercise increased GSSG levels in COPD subjects but not in healthy control. The rise in GSSG indicates 
that antioxidant buffering is less effective and that activity of unbuffered oxidants is increased in COPD patients. 
This is in conjunction with other studies [37]-[39].  
There was heterogeneity in the acute exercise induced cytokine response between subjects and the evidence 
available is contradictory. However, this is not very surprising given the several factors that are known to influ-
ence acute exercise induced cytokine response including body mass composition, age and gender. The type, lev-
el and duration of exercise, for instance, seem to influence the outcome of the cytokine response. The duration 
of exercise seems to be positively correlated with the amount of cytokine release which might have caused dif-
ferences between measurements in healthy people and in patient groups, because generally patients are fatigued 
earlier and thus exercise for a shorter period of time.  
4.2. The Effect of Pulmonary Rehabilitation 
There was no modification to cytokine levels after the 8-week period of rehabilitation.  
Rabinovich and associates [40] showed that the 8-wk protocol of high-intensity training had the expected ef-
fect in control subjects. Compared with the untrained state, the trained vastus lateralis muscle maintained GSH 
at significantly higher levels after a bout of exhaustive exercise. Thus, training appeared to increase the efficacy 
of antioxidant buffering in control subjects as expected [41]. No such benefit was seen in individuals with 
COPD. GSH concentrations measured after exhaustive exercise were unaltered by training. Worse, training in-
creased the GSSG levels measured after exhaustive exercise. The latter finding is contradictory to the findings in 
the current study. Acute exercise increased GSSG levels in COPD subjects but not in healthy control, however, 
after 8-week rehabilitation, GSSG levels were unaltered after exercise but instead there was trend toward reduc-
tion in GSSG values but didn’t reach statistical significance, Figure 5.   
Mercken reported that PR was associated with reduced oxidative stress after submaximal exercise in patients 
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with COPD [28]. In the COPD group in our study, peak exercise samples were taken at exhaustion rather than at 
the same duration of exercise before PR (isotime). The duration of endurance exercise was 74% longer after PR 
(p = 0.0003). Measurements of oxidative stress at isotime may have demonstrated significant differences before 
and after PR, as inflammatory response increases with the intensity and duration of exercise. The type of physi-
cal activity and its intensity and duration seem to be highly relevant to differences in the cytokine response to 
exercise [42]. 
4.3. Limitations of the Study 
There are several limitations of the current worth discussing. A relatively small number of healthy subjects were 
included in the study. Despite the small size, we note the large standard deviations for cytokine response and 
consistency of our results. Our COPD patient sample is representative of the COPD regularly seen in clinical 
practice.  
Although the statistical model aims to adjust for the possible confounding factors, the existence of some un-
controlled effects cannot be excluded. Our results could also be affected by other drawbacks. Of the COPD pa-
tients in our study, almost all patients used inhaled corticosteroids and 12% used systemic corticosteroids. This 
could contribute to the underestimation of the difference in systemic biomarkers between COPD patients and 
control subjects. Nevertheless, the effect of inhaled corticosteroids on inflammatory biomarkers is still contro-
versial. Other chronic conditions, such as chronic heart failure or diabetes, also appear to be associated with a 
similar systemic inflammatory process. Several studies have described that these disorders are more frequent in 
COPD patients and, therefore, might also contribute to their pro-inflammatory state. In order to analyze only the 
effect of COPD as an independent factor, we have carefully excluded these conditions from the present study. 
5. Conclusion 
In conclusion, these data support the now well-established view that systemic inflammation is higher in patients 
with COPD and that systemic inflammatory mediators are associated with disease severity. Furthermore, exer-
cise-induced inflammatory response was higher but not exaggerated in COPD. Finally, our hypothesis that pul-
monary rehabilitation may modify pro-inflammatory mediators, as long-term training in healthy subjects does 
[43], has not been demonstrated in this study. 
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